LHC 1300.3058
AP Patient Care
Reviewed 1/14
ATTENTION DEFICIT DISORDER (ADD)
PURPOSE:
To accurately diagnose and provide appropriate medical treatment for ADD while identifying potential
comorbidities and reducing the risk of controlled substance abuse at Kansas State University.
POLICY:
All patients presenting to Lafene Health Center with symptoms and/or signs suggestive of ADD or for
refills on Schedule II stimulant medications prescribed for ADD (e.g. Ritalin, Concerta, Dexedrine,
Adderall) must be thoroughly evaluated and provide documentation of a definitive diagnosis of ADD
prior to receiving a prescription from a Lafene provider for any of the medications. Realizing there is
no single “gold standard” diagnostic test, it is not the responsibility of a Lafene provider to determine
which specific tests are necessary. However, it is required that the comprehensive diagnostic
evaluation shall include the following components:
1. Clinical interview to include developmental history and assessment of the impact
the student’s symptoms have on current school, occupational and relationship
functioning.
2. Assessment of attention, concentration, distractibility and short-term memory
3. Cognitive and achievement tests
4. Assessment for presence of other psychiatric disorders and substance abuse
5. Medical examination including any appropriate laboratory tests
Example of tests or assessment tools sometimes utilized include:
1.
2.
3.
4.
5.
6.
Connors AD / HD Rating Scale
Wechsler Adult Intelligence Scale III
Woodcock-Johnson III Cognitive and Achievement Test
MCMI-III (mood and personality assessment)
MMPI
Brown Scale – Adult ADD